GlassScriptPhysician profile
Edinrin Obasare
NPI 1093027278
$94,372.73
in general payments reported to CMS, 2019-2025
33 companies · $16K in 2025
The $16K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,854 · 2020: $8,534 · 2021: $16K · 2022: $22K · 2023: $15K · 2024: $7,396 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $20K · Food and Beverage: $19K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $19,917.05 |
| Food and Beverage | $18,802.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $33,853.79 | 2020-2025 | Acticor 7 Vr-T Dx, Selectra, Edora 8 Dr-T |
| Medtronic, INC. | $14,049.53 | 2021-2025 | Linq II, Azure Xt Dr Mri Surescan, Micra |
| Boston Scientific Corporation | $11,845.51 | 2019-2025 | Farapulse, General - Therapies, Rhythmia Mapping System |
| Abbott Laboratories | $10,423.73 | 2019-2025 | Perclose Prostyle, Amplatzer Amulet, Aveir |
| Medical Device Business Services, INC. | $8,550.45 | 2019-2024 | Carto 3, Qdot Micro Catheter |
| Atricure, INC. | $3,774.36 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $2,759.00 | 2019-2020 | |
| Biosense Webster, INC. | $2,604.51 | 2019-2025 | Carto 3, Qdot Micro Catheter, Visitag Surpoint External Processing Unit |
| Janssen Pharmaceuticals, INC | $1,741.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,534.16 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $561.97 | 2021-2023 | |
| Amgen INC. | $454.35 | 2021-2022 | |
| Cardiva Medical, INC. | $315.13 | 2019-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Sanofi-Aventis U.S. LLC | $248.98 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $186.49 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $172.06 | 2021-2022 | |
| Pfizer INC. | $141.84 | 2020-2023 | |
| Heartflow, INC. | $131.12 | 2024 | |
| Ge Healthcare | $130.78 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.23 | 2020-2023 | Jardiance |
| Impulse Dynamics (USA) INC. | $113.49 | 2023 | Optimizer |
| Kestra Medical Technology Services, INC. | $109.62 | 2022 | |
| Edwards Lifesciences Corporation | $106.27 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $95.73 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $83.17 | 2022 | |
| Glaxosmithkline, LLC. | $58.19 | 2021-2022 | |
| Abiomed | $48.81 | 2025 | |
| Jazz Pharmaceuticals INC. | $38.61 | 2022 | |
| Mallinckrodt Hospital Products INC. | $34.99 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $27.67 | 2022 | |
| Bracco Diagnostics INC. | $22.86 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.96 | 2022 | |
| Amarin Pharma, INC. | $12.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edinrin Obasare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.